Special Issue "Application of Novel Method in Pharmaceutical Study"
Deadline for manuscript submissions: 30 November 2018
Dr. Zhaogang Yang
Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH 43210, USA
Interests: innovative nanotechnologies, exosome, gene therapy, nanochannel electroporation, nanoparticle drug delivery
With the improvements in medical treatment levels, the prevention and treatment of diseases that are difficult to cure have made important progress. Currently, a wide variety of drug formulations and technologies have been explored in malignant tumors, cardio cerebral vascular disease, anti-infection, geriatric diseases, etc. However, a number of problems still need to be solved before their utilization can become routine. These issues include low solubility, poor penetration into cells, hepatic disposition, narrow therapeutic index, rapid uptake by normal tissues, low bioavailability and high costs. Additionally, therapeutic drugs may have unfavorable pharmacokinetic parameters, such as a fast clearance rate and short terminal elimination half-life. Moreover, the emergence of drug resistance involving multiple mechanisms is a major obstacle to successful application in clinics. Therefore, in order to solve these problems, various novel strategies must be applied to pharmaceutical research. These methods include: Nanotechnology for the delivery of drugs, active targeting delivery of drugs for diseases therapy, scientific application of polymer materials and molecular biological methods, and so on.
The purpose of this Special Issue is to present a series of application of novel methods in pharmaceutical study. We are committed to acquiring high-tech drugs that are fixed-time, fixed-position, and quantitative release. We hope these novel methods can help us overcome all the obstacles above.
Prof. Dr. Lesheng Teng
Dr. Zhaogang Yang
Prof. Dr. Jing Xie
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.